Comparative analysis of efficacy and safety between D-TACE + HAIC + lenvatinib and D-TACE + lenvatinib in the treatment of unresectable massive hepatocellular carcinoma

Abstract Objective The aim of this study was to investigate the efficacy and safety of the combined treatment regimen of D-TACE, HAIC, and Lenvatinib in patients with massive hepatocellular carcinoma, with the goal of providing a safer and more effective therapeutic strategy for individuals sufferin...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Haohao Lu, Bin Liang, Chuansheng Zheng, Xiangwen Xia
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BMC 2024-11-01
Ráidu:	BMC Cancer
Fáttát:	Massive hepatocellular carcinoma Drug-eluting bead transarterial chemoembolization Hepatic arterial infusion chemotherapy Targeted therapy Tyrosine kinase inhibitor Lenvatinib
Liŋkkat:	https://doi.org/10.1186/s12885-024-13179-5
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!